skip to main content

Motor Neurone Disease (MND)

Diagnosis and management of MND/ALS.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Neurology
Turn this into CPDPractise this topic, identify learning gaps and prepare a CPD draft you can review.Find reviewed question practiceChoose your examination. iatroX will check for an exact reviewed question set before offering a topic; no filter or session starts automatically.
regional clinical guidance

Motor Neurone Disease (MND): guidance by region

Recommendations, thresholds and pathways can differ. Open the page written for the jurisdiction you need.

United StatesAmyotrophic lateral sclerosis recognition and multidisciplinary careNeurology · reviewed 2026-08-20CanadaMotor neurone diseaseNeurology · reviewed 2026-08-20AustraliaMotor neurone disease: source-status boundaryNeurology · reviewed 2026-08-20

Clinical Guidelines

Motor neurone disease: assessment and management | NICE
National
Motor neurone disease: assessment and management NICE
National
NICE guideline [NG42]
National
NICE guideline [NG42]: Motor neurone disease: assessment and management
National
NICE guideline [NG42]: Motor neurone disease: assessment and management (Recommendations)
National
ESPEN guideline clinical nutrition in neurology
Local
Motor neurone disease: assessment and management (NICE guideline NG42, full guideline)
Local
New Zealand Best Practice Recommendations For The Care Of People With MND
Local
NICE guideline [NG42]: Motor neurone disease: assessment and management
Local
The Australian MND Guideline
Local